In STEP 1-3 clinical trials, a weekly dose of 2.4 mg semaglutide resulted in a 49% reduction in C-reactive protein (CRP) levels, while a 1 mg weekly dose led to a 42% decrease, compared to placebo after 68 weeks
Im noticing that a lot of people are saying that they dont want to be on medication forever, Kumar said
Employers are still not necessarily understanding these drugs, as there's not a lot of data out there to determine the side effects, she said
However, individual responses to medications vary
To identify suitable drugs, we trained algorithms to predict eGFR in MetaCardis patients with T2D, where TMAO appears to have the biggest impact on kidney function, using prescribed medication as input